Cumba, Guendelyn .

HRN: 25-55-15  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2024
CEFUROXIME 1.5GM (VIAL)
09/20/2024
09/22/2024
IV
4 Doses 1.5gm
Q8
Post Op
Waiting Final Action 
09/20/2024
CEFUROXIME 500MG (TAB)
09/20/2024
09/26/2024
PO
500mg
BID
Post Op
Waiting Final Action 
09/20/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/20/2024
09/22/2024
IV
500mg
Q8
Post Op
Waiting Final Action 
09/20/2024
METRONIDAZOLE 500MG (TAB)
09/20/2024
09/26/2024
PO
500mg
Tid
Postop
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: